Evaluation of oil/water-type cyclosporine gel ointment with commercially available oral solution

Drug Development and Industrial Pharmacy

Volumn 23, Issue 3, 1997, Pages 285-291

  Tamura, Takashi ^a   Takayama, Kozo ^b   Satoh, Hiroshi ^a   Tanno, Keiki ^a   Nagai, Tsuneji ^b  

^a NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

^b HOSHI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; CYCLOSPORIN A; WATER OIL CREAM;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROGEL; MALE; NONHUMAN; OINTMENT; PARTICLE SIZE; PHYSICAL CHEMISTRY; RAT; SKIN PENETRATION; SKIN PERMEABILITY;

EID: 0030949375     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.3109/03639049709149805     Document Type: Article

References (25)

1. W. M. Bennett and D. J. Norman, Ann. Rev. Med., 37, 215 (1986).
2. (a) R. Y. Calne, D. J. G. White, D. B. Evans, S. Thiru, R. G. Henderson, D. V. Hamilton, K. Rolles, P. Mcmaster, T. J. Duffy, B. R. D. Macdougall, and R. Williams. Br. Med. J., 282, 934 (1981).
3. (b) P. E. Oyer, E. B. Stinson, S. W. Jamieson, S. A. Hunt, M. Perlroth, M. Billingham, and N. E. Shumway, Transplant Proc., 15, 2546 (1983).
4. T. Beveridge, W. Maurer, T. W. Poole, E. Wiskott, and A. J. Wood, Lancet, 330, 9 (1983).
5. B. D. Kahan, Am. J. Kidney Dis., 3, 444 (1984).
6. (a) J. Marks, Br. Med. J., 293, 509 (1986).
7. (b) C. E. M. Griffiths, A. V. Powles, J. N. Leonard, L. Fry, B. S. Baker, and H. Valdimarsson, Br. Med. J., 293, 731 (1986).
8. D. D. Picascia, J. M. Garden, R. K. Freinkel, and H. H. Roenigk, J. Am. Acad. Dermatol., 17, 408 (1987).
9. M. M. H. M. Heinardi, W. Westerhof, and J. D. Bos, Br. J. Dermatol., 116, 269 (1987).
10. (a) H. Barthelemy and J. Thivolet, Cyclosporin in Autoimmune Diseases (R. Schindler, ed.), Springer-Verlag, New York, 1985, p. 215.
11. (b) R. B. Nussenblatt, A. G. Palestine, C. C. Chan, M. Mochizuki, and K. Yancey, Arthritis Rheum., 28, 671 (1985).
12. T. Van Joost, E. Stolze, and F. Heule, Arch. Dermatol., 123, 166 (1987).
13. C. A. Biren and R. J. Barr, Arch. Dermatol., 122, 1028 (1986).
14. R. Arkey, ed., Physicians' Desk Reference, 49th ed., Medical Economics Data Production Company, Montvale, NJ, 1995, p. 2183.
15. (a) G. B. G. Klintmalm, S. Iwatsuki, and T. E Starzl, Lancet, 328, 470 (1981).
16. (b) J. M. Hows, J. M. Smith, A. Baughan, and E. C. Gordon Smith, Transplant. Proc., 15, 2708 (1983).
17. A. Parodi and A. Rebora, Arch. Dermatol., 123, 165 (1987).
18. R. D. Aldridge, H. F. Sewell, G. King, and A. W. Thomson, Clin. Exp. Immunol., 66, 582 (1986).
19. C. E. M. Griffiths, A. V. Powles, B. S. Baker, L. Fry, and H. Valdimarsson, Lancet, 334, 80 (1987).
20. M. Mizoguchi, K. Kawaguchi, Y. Ohsuga, Y. Ikari, A. Yanagawa, and Y. Mitzushima, Lancet, 339, 1120 (1992).
21. JP P 5-310591.
22. F. P. Schmook, A. Stuetz, and J. Reinhardt, Skin Pharmacol., 6, 116 (1993).
23. R. J. Scheuplein and I. H. Blank, Physiol. Rev., 51, 702 (1971).
24. (a) P. A. Jacobson, C. J. Maksym, A. Landvay, N. Weiner, and R. Whitmore, Am. J. Hosp. Pharm., 50, 687 (1993).
25. (b) H. L. McLeod, T. R. McGuire, and G. C. Yee, Ann. Pharmacother., 26, 172 (1992).